Sponsor:
M.D. Anderson Cancer Center
Code:
NCT02107105
Conditions
Rectal Adenocarcinoma
Stage I Rectal Cancer AJCC v8
Stage II Rectal Cancer AJCC v8
Stage IIA Rectal Cancer AJCC v8
Stage IIB Rectal Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quality-of-Life Assessment
Questionnaire Administration
Brief summary:
Conditions
Rectal Adenocarcinoma
Stage I Rectal Cancer AJCC v8
Stage II Rectal Cancer AJCC v8
Stage IIA Rectal Cancer AJCC v8
Stage IIB Rectal Cancer AJCC v8
Study ID
NCT02107105
Start date
May 16, 2014
Status verified date
Aug, 2026
Completion date
May 31, 2030
Anticipated
Primary completion date
May 31, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
430 participants
Anticipated
Arms
Observational (questionnaire)
Interventions
Quality-of-Life Assessment
Questionnaire Administration
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
George J. Chang
713-792-6940Principal Investigator:
George J. Chang
Sponsor
M.D. Anderson Cancer Center
Last update posted
Aug 31, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-08-31.